NCT03758170View on ClinicalTrials.gov

High-Dose Steroid for Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Postoperative PainPostoperative Nausea and VomitingKnee OsteoarthritisPerioperative/Postoperative ComplicationsSurgery
Interventions
DRUG

Dexamethasone

An intravenous bolus dose of dexamethasone given prior to surgery.

Trial Locations (2)

2650

Hvidovre Hospital, Capital Region of Denmark., Hvidovre

7100

Vejle Sygehus, Vejle

All Listed Sponsors
collaborator

Sygehus Lillebaelt

OTHER

lead

Copenhagen University Hospital, Hvidovre

OTHER

NCT03758170 - High-Dose Steroid for Knee Arthroplasty | Biotech Hunter | Biotech Hunter